Quidel

DHI Cell Culture & Fluorescent Tests

Helicase Dependent Amplification Assays

Fluorescent Antibody Kits & Reagents

Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018

SAN DIEGO–(BUSINESS WIRE)–Jul. 17, 2018–

Quidel Corporation (NASDAQ: QDEL),a provider of rapid diagnostic

testing solutions, cellular-based virology assays and molecular

diagnostic systems, will report second quarter 2018 financial results

after market close onTuesday, August 7, 2018.

Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.

To place orders, get assistance with shipments, pricing or contract administration view ourCustomer Supportpage.

Visit ourTechnical Supportpage to get help with product specifications, supporting docs or general support issues.

NEW: Register to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.

In the U.S. 1.800.874.1517/ Outside the U.S. 1.858.552.1100 or Contact Your Local Distributor

Helicase Dependent Amplication Assays

DHI Cell Culture & Fluorescent Tests

California Transparency in Supply Chains

Quidel Corporation Headquarters:12544 High Bluff Drive, Suite 200, San Diego, CA 92130, USA858.552.1100 Tel 858.453.4338 Fax

Copyright © 2008-2018 Quidel Corporation. All rights reserved.

Website Terms and ConditionsPrivacy PolicySite Map

By accessing, browsing and/or using this website, you acknowledge that you have read, understood, and agree to be bound by QuidelsWebsite Terms and Conditions,Privacy Policyand to comply with all applicable laws and regulations. If you do not agree to these terms, do not use the website. Additionally, this website contains information on products that is targeted to many different audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for your accessing such information that may not comply with any legal process, regulation, registration or usage in the country of your origin.